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Abstract
Background: Many health care practitioners use a variety of hands-on treatments to improve
symptoms and disablement in patients with musculoskeletal pathology.
Research to date indirectly suggests a potentially broad effect of manual therapy on the
neuromotor processing of functional behavior within the supraspinal central nervous system (CNS)
in a manner that may be independent of modification at the level of local spinal circuits. However,
the effect of treatment speed, as well as the specific mechanism and locus of CNS changes, remain
unclear.
Methods/Design: We developed a placebo-controlled, randomized study to test the hypothesis
that manual therapy procedures directed to the talocrural joint in individuals with post-acute ankle
sprain induce a change in corticospinal excitability that is relevant to improve the performance of
lower extremity functional behavior.
Discussion: This study is designed to identify potential neuromotor changes associated with
manual therapy procedures directed to the appendicular skeleton, compare the relative effect of
treatment speed on potential neuromotor effects of manual therapy procedures, and determine
the behavioral relevance of potential neuromotor effects of manual therapy procedures.
Trial Registration: http://www.clinicaltrials.gov identifier NCT00847769.
Background
Many health care practitioners use a variety of hands-on
treatments to improve symptoms and disablement in
patients with musculoskeletal pathology. Often, these
manual procedures purport to target specific musculoskel-
etal structures, such as joints, muscles, or fascia. Proce-
dures that historically have been relevant to joint
structures may be placed on a continuum of speed and
amplitude. Mounting scientific evidence supports statisti-
cally significant and clinically important benefits of man-
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ual therapy in subgroups of patients with various forms of
musculoskeletal disablement affecting the axial region [1-
3] and appendicular region. [4-9] However, studies
related to the mechanisms of manual therapy interven-
tions have lagged behind the literature documenting their
clinical effects. An improved understanding of the mech-
anism of clinical improvement with various speeds and
amplitudes of manual therapy will lead to the optimiza-
tion of patient selection for manual therapy procedures.
In turn, improved patient selection will optimize effi-
ciency, quality, and cost of health care for patients with
musculoskeletal disablement.
Various central and spinal sensorimotor mechanisms of
manual therapy procedures recently have been investi-
gated. Inhibition of the Hoffman reflex following spinal
manipulation and increased lower extremity muscle
strength have been observed following manual therapy
directed to the lumbopelvic region in several studies. [10-
14] Manual therapy procedures may facilitate descending
GABAergic inputs to local spinal circuits that cause the
observed H-reflex depression, suggesting a broader effect
on the central nervous system (CNS).[15] However, rela-
tively few studies to date have looked into short-term neu-
roplastic changes in CNS neuromotor processing to
manual therapy procedures. To that extent, Dishman and
colleagues[16] identified a short-term increase in motor
evoked potential amplitude for the lumbar paraspinals in
healthy volunteers using single-pulse transcranial mag-
netic stimulation (TMS) directed to contralateral motor
cortex. Haavik-Taylor and Murphy[17] also documented a
significant muscle-specific pattern of effects of cervical
spine manipulation on short interval intracortical facilita-
tion, short interval intracortical inhibition, and cortical
silent period of abductor pollicis brevis and extensor indi-
cis without significant change in F wave in asymptomatic
individuals with a history of recurrent neck pain.
Taken together, these results suggest a potentially broad
effect of manual therapy on the neuromotor processing of
functional behavior within the supraspinal CNS in a man-
ner that may be independent of modification at the level
of local spinal circuits. However, several important limita-
tions of existing studies continue to constrain our collec-
tive understanding of the CNS changes associated with the
clinical effects of manual therapy in patients with muscu-
loskeletal disablement. The use of non-disabled volun-
teers in the majority of existing research to date may
provide limited information regarding the specific effects
of mobilization and manipulation in patients with disa-
blement due to pain and weakness. The use of spinal man-
ual therapy as a subject of study potentially jeopardizes
the specificity of conclusions that can be drawn, since spi-
nal manipulation is poorly localized even in skilled and
experienced practitioners.[18] The absence in the litera-
ture to date of behavioral measures to document potential
changes in physical performance as a result of manual
therapy procedures means the functional relevance of
observed CNS neuroplasticity associated with cervical and
lumbar manipulation also remains unclear. Also, the
effect of procedure speed on CNS neuroplasticity has yet
to be examined. A comparison of procedures character-
ized by a high velocity-low amplitude (HVLA) application
of iatrogenic force with procedures that involve a slower,
variable-amplitude application of iatrogenic force would
be relevant, because they are among the most common
clinical procedures in manual therapy.
One promising research design for determining the
underlying neural mechanism associated with manual
therapy involves the talocrural joint. There are a number
of advantages for using the talocrural joint as an experi-
mental preparation for studying the neurophysiological
effects of manual therapy procedures. These include (i)
the relatively large size of the talocrural joint, (ii) the rela-
tively large size of the muscle groups crossing this joint,
and (iii) the talocrural joint is subject to a prevalent injury
that may be identified on the basis of a simple history and
clinical examination. The large size of the talocrural joint
suggests manual therapy procedures may be more specifi-
cally directed to this region than a smaller joint of the
spine. The relatively large size of the muscles crossing the
talocrural joint provide for easily reproducible recording
sites for transcranial magnetic stimulation with electro-
myographic recording (TMS/EMG). Valid and reliable
behavioral measurements for talocrural joint range of
motion and lower extremity functional behavior exist.
These measurements will allow for empirical examination
of the relationship between short-term CNS neuroplastic-
ity and the changes in functional behavior that have been
elucidated by clinical studies.
The purpose of this paper is to describe methodology for
using the talocrural joint as an experimental preparation
to study the neuroplastic CNS changes associated with
mobilization and manipulation. The specific aims of this
study are to (1) determine the same-day test-retest relia-
bility of TMS/EMG in individuals with post-acute ankle
sprains, (2) quantify corticospinal excitability in individ-
uals with post-acute ankle sprains receiving HVLA ankle
manual therapy, slow ankle manual therapy, and control
intervention; and (3) relate changes in corticospinal excit-
ability in individuals with post-acute ankle sprains receiv-
ing HVLA ankle manual therapy, slow ankle manual
therapy, and control intervention to short-term changes
in lower extremity function.BMC Neurology 2009, 9:20 http://www.biomedcentral.com/1471-2377/9/20
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Methods/Design
Subjects
Subjects with post-acute ankle sprains (n = 27) will be
enrolled into the study. Inclusion criteria include (i) sub-
ject age between 18–60 years, (ii) onset of ankle sprain at
least 2 weeks prior to enrollment, (iii) Foot and Ankle
Ability Measure Activity of Daily Living subscale score
>20%, and (iv) ankle dorsiflexion range of motion limita-
tion greater than 2 standard deviations from published
values.[19] Exclusion criteria include (i) assisted ambula-
tion (eg, cane or crutches); (ii) inability to bear weight
through the affected extremity immediately after injury;
(iii) tenderness to palpation of the medial and lateral
malleolar zones, styloid process of the 5th metatarsal, and
navicular[20]; (iv) positive anterior drawer or talar tilt
dimple test suggesting ligamentous laxity [21-23]; (v) vol-
ume of the affected limb greater than 10% of the unaf-
fected limb per water displacement volumetry[24]; (vi)
previous history of ligament or bony reconstructive sur-
gery to the ankle and foot; (vii) concomitant injury to
other lower extremity joints; and (viii) medical conditions
that serve as contraindications to mobilization/manipula-
tion and transcranial magnetic stimulation, such as pres-
ence of pacemaker, metal in head, pregnancy,
neurological disorders, recent use of stimulants or medi-
cations known to lower seizure threshold, and personal or
family history of seizures.[25,26]
A total of 27 subjects will be recruited for this study (n = 9
per group). This sample size will provide >80% statistical
power to detect differences in lateral star balance excur-
sion performance based on an effect size d = 1.47 from
Hale and colleagues[27] involving change in SBET score
due to an exercise-based rehabilitation program in indi-
viduals with ankle sprains. Therefore, this study was pow-
ered to detect between-group differences in the selected
lower extremity functional behavior following talocrural
manipulation, which is thought to be the dependent var-
iable in this study that will demonstrate the greatest inter-
subject variability.
Research Design
Subjects each begin with pre-intervention TMS measures
(motor thresholds and input-output curves), ankle range
of motion (ROM) tests, and lower extremity functional
behavior tests. Each pre-intervention measurement will be
taken a total of 2 times with a 30 minute rest break
between measurements. Subjects will then be randomized
into 1 of 3 comparison groups, each to receive a different
manual therapy intervention. Immediately following the
intervention, subjects will receive post-intervention TMS
measures, ankle ROM tests, and lower extremity func-
tional behavior tests, identical to the pre-intervention
assessments.
Procedure
All subjects who meet the inclusion and exclusion criteria
will be eligible for participation (Figure 1). Potential sub-
jects also will be screened prior to enrollment into this
study to determine presence of decreased ankle dorsiflex-
ion range of motion (ROM) greater than 2 standard devi-
ations from published norms for standard procedures for
range of motion.[19] Upon arrival on the day of testing,
participants will complete a 15-minute intake interview
that includes questions about their medical and psychiat-
ric history, and their current use of alcohol, nicotine and
prescription or non-prescription drugs. The purpose of
the interview is to obtain more detailed information
about any factors that may influence either their eligibility
to participate in the TMS/EMG procedures or the results of
the TMS/EMG measurements themselves. Patients will
then receive pre-intervention testing, randomization into
intervention groups and study-related intervention, and
post-intervention testing. Study procedures will last up to
3 hours. The Institutional Review Board of the University
of Southern California (Los Angeles, CA, USA) approved
the study protocol.
Pre-intervention testing
After informed consent is obtained, subjects will receive
pre-intervention testing. Pre-intervention testing will
include:
TMS measurement
A single-pulse magnetic stimulator (Magstim 2002) will
be used to carry out all TMS studies. A Double Cone 110-
millimetre (mm) coil that provides sufficient depth of
penetration to reliably stimulate cortical representation of
ankle musculature will be used in this study. Subjects
from each intervention group will undergo TMS testing
both pre- and post-intervention. The primary motor cor-
tex of the hemisphere contralateral to the impaired ankle
will be tested. The pre-intervention session will consist of
(i) identifying optimal coil position ('hot spot') and
motor threshold (MT) for the target leg muscles (tibialis
anterior and gastrocnemius), (ii) conducting input-out-
put (IO) curve studies of both muscles, (iii) input-output
curve studies will be conducted both with the muscles at
rest and with the muscles pre-activated (active contraction
condition). The pre-activated condition is required to gen-
erate cortical silent period data.
Surface EMG electrodes will be attached over tibialis ante-
rior and gastrocnemius. The EMG signal will be filtered
with a bandpass of 1–1000 Hz, amplified, and digitized at
2000 Hz. The data will be graphically displayed and
stored for later analysis in 600-millisecond (ms) samples
beginning 100 ms before TMS onset (custom written
MATLAB module for analog-to-digital sampling (dwaq;
dataWizard acquisition, ADW). For the active contractionBMC Neurology 2009, 9:20 http://www.biomedcentral.com/1471-2377/9/20
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Flow diagram for subjects' screening, testing, and intervention Figure 1
Flow diagram for subjects' screening, testing, and intervention.BMC Neurology 2009, 9:20 http://www.biomedcentral.com/1471-2377/9/20
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condition the subject will be asked to perform maximal
dorsiflexion and maximal plantarflexion against a load
cell, with care taken to minimize contribution from other
muscle groups at the thigh or pelvis. The largest of three
attempts is taken as the maximum voluntary contraction
force (MVC).
To determine optimal TMS coil location and orientation,
TMS pulses are delivered while the subject contracts the
ankle musculature and at an inter-stimulus interval of 5–
10 seconds. The coil is initially placed at the vertex and the
optimal scalp position for TMS ('hot spot') is determined
by moving the coil a few centimetres (cm) in each direc-
tion from this position and observing the site at which the
largest motor evoked potential (MEP) is produced at
supra-threshold intensities. The initial muscle contraction
serves to facilitate induction of MEPs and is used to aid in
finding the motor hot spot.
Brainsight™ Frameless is a stereotactic image guidance sys-
tem that will facilitate the positioning of the TMS coil over
a subject's brain (Figure 2). With Brainsight, variability in
TMS measures taken at different time points will be
greatly minimized as the motor 'hot spot' for each muscle
Screenshot image from Brainsight stereotactic image guidance software used to localize motor hotspot Figure 2
Screenshot image from Brainsight stereotactic image guidance software used to localize motor hotspot. A 3-
dimensional reconstruction (A, bottom image) of a single T1 magnetic resonance scan of the brain (B) with positioning of the 
transcranial magnetic stimulation coil. An infrared optical sensor co-registers the position and orientation of the TMS coil rela-
tive to small refractory markers on the subject's cranium (A, top image). This provides the investigator with real-time informa-
tion regarding the brain locus that will receive TMS given a position and orientation of the TMS coil, in order to minimize 
spatial variability in TMS application. (Image courtesy of Roch M. Comeau, Brainsight, Rogue Industries, Canada.).BMC Neurology 2009, 9:20 http://www.biomedcentral.com/1471-2377/9/20
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is marked on a 3D reconstruction of a standard magnetic
resonance image of the brain at the pre-intervention
measurement and then the same hot spot location
becomes the site of stimulation at the post intervention
assessment. A single T1-weighted MRI Scan will be used
with the interactive frameless stereotactic system (Brain-
sight, Rogue Industries, Canada) to guide precise location
of the TMS coil and stimulate the appropriate muscle rep-
resentation in M1. With Brainsight technology a 3D
reconstruction of an MRI scan can be made. Subjects will
sit in a chair with their head secured. Landmarks on the
subject's head will be co-registered with landmarks on the
structural MRI to allow tracking of the position of the TMS
coil with respect to the underlying cortex. The position of
the TMS coil and the subject's head are co-registered from
small pieces of refractory material (trackers) placed on
them. An infrared optical position sensor monitors the
trackers. This information is sent to a computer, which
after a calibration procedure displays the position and ori-
entation of the coil relative to the MRI. After the motor
'hot spot' for the tibialis anterior and gastrocnemius mus-
cles are identified, the coil location and orientation is then
marked on the anatomic MRI using Brainsight. All subse-
quent TMS pulses will then be delivered with the coil
placed in the same location and orientation as this hot
spot.
Motor threshold (MT)
MT is defined as the lowest TMS intensity required to elicit
a small, clearly discernable MEP at least 50% of the time
(50 microvolts [μV] for resting muscles, 100 μV for mus-
cles under active contraction). Within a given individual,
MT is stable across TMS sessions which assures that supra-
threshold TMS intensities expressed as a percentage of MT
can be reliably compared between TMS sessions.[28]
The following procedure for determining active MT will
apply for testing the tibialis anterior and gastrocnemius.
Active contraction corticomotor excitability data will be
collected with the muscles at 10% of the subject's MVC.
The coil is oriented and positioned with the handle of the
coil pointing backward to induce posterior to anterior cur-
rent flow across the primary motor cortex. For determina-
tion of active MT, the subject makes a steady, minimal
background contraction against a load cell (10% of MVC)
with the help of audiovisual feedback. TMS pulses are
delivered while the subject contracts and at an inter-stim-
ulus interval of 5–10 seconds. The coil is initially placed
at the vertex. Optimal coil location for TMS ('hot spot') is
determined by moving the coil a few cm in each direction
from this position and observing the site at which the larg-
est MEP is produced at supra-threshold intensities. This
optimal coil location is then marked on the 3D MRI using
Brainsight and the coil is fixed at this location on the scalp
using a clamp and external support. TMS intensity is then
decreased by 1–2% intervals. TMS MT for the muscle is the
TMS intensity where at least 5 of 10 responses generate
peak-to-peak MEP amplitudes of at least 50 μV for the
resting condition and 100 μV for the active contraction
condition. Alterations in corticomotor system excitability
will be assessed as changes in MEP and cortical silent
period duration (CSP) input-output curve characteristics
between pre- and post-intervention time points for the
three groups. TMS intensities for this study will be
expressed as a percentage of MT.
MEP input-output curves
Input-output (IO) curves will be generated by keeping the
TMS coil at its optimal hotspot and varying TMS intensity
(i.e., input) at 5% intervals from 95% (subthreshold) to
140% (suprathreshold) of MT. At all intensities, 8 single-
pulse TMS stimuli will be delivered under each of 2 con-
ditions: (i) at rest and (ii) simultaneous with an active
contraction of the muscle (5–10 seconds between stim-
uli). The order of TMS intensities will be varied randomly.
CSP input-output curves
Silent period durations depend largely on the intensity of
the TMS stimulus delivered over the 'hot spot' of a pre-
activated target muscle. The active muscle contraction
condition will be standardized by (i) using audio-visual
feedback provided to the subject for consistent levels of
muscle contraction (10% MVC) and (ii) triggering TMS
discharge when EMG activation is maintained at 10%
MVC. As such, CSP durations will be obtained during IO
curve studies. At each trial, the duration of the silent
period will be calculated as the time between (i) when rec-
tified EMG activity drops below average pre-TMS EMG
activity (10% MVC) and (ii) when rectified EMG activity
rises above that average pre-TMS EMG activity.
The relationship between the size of the MEP and the
duration of the silent period versus stimulus intensity can
be illustrated as a sigmoidal shape. As such, measured
characteristics of the IO curve will be extracted using the
Boltzmann sigmoidal function to fit the data points by the
Levenberg-Marquard nonlinear least-mean-squares algo-
rithm.[29] The Boltzmann equation relating the ampli-
tude (MEP) and duration (CSP) of the response with the
stimulus intensity has three parameters: the maximum
value (i) MEPmax, the plateau of the relation, (ii) the stim-
ulus intensity (S50) required to obtain a response 50% of
the maximum, (iii) and the maximum slope parameter.
H-reflex
In order to determine whether potential changes in TMS-
assessed corticospinal excitability pre- and post-interven-
tion are spinally and/or centrally mediated the Hoffmann
(H) reflex will be performed. The H reflex is considered
the electrical analogue of the tendon stretch reflex. Since itBMC Neurology 2009, 9:20 http://www.biomedcentral.com/1471-2377/9/20
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bypasses the effects of gamma motoneurons and muscle
spindle discharge, it can be used as a method for assessing
spinal reflex excitability in intact human subjects before
and after intervention.[30] The H-reflex will be elicited
using a Cadwell Sierra Wave EMG Nerve Conduction
Device (Cadwell Laboratories, Kennewick, WA, USA) by
selective electrical stimulation of the Ia fibers of the poste-
rior tibial nerve at the popliteal fossa. In response to affer-
ent nerve stimulation, H-waves can then be recorded as
MEPs using surface EMG electrodes over the soleus mus-
cle. Such stimulation can be accomplished by using slow
(less than 1 pulse/second), long-duration (0.5–1 ms)
stimuli with gradually increasing stimulation intensity. As
stimulator intensity increases, the peak-to-peak H-wave
amplitude gets larger and a direct short-latency motor
response (M-wave) also begins to develop. The M-wave
indicates that orthodromic motor fibres are now being
directly stimulated at higher intensities. Finally, at
supramaximal intensity stimulation, the H-wave disap-
pears because antidromic motor stimulation completely
blocks descending H-reflex conduction, and only the
direct M-wave can be observed.
Electrode placement
Subjects are positioned prone with the leg to mid thigh
exposed. The active electrode is placed 1/3 of the distance
up from the intermalleolar line to the popliteal fossa (or
at the base of the bulk of the calf muscle). The reference
electrode is located midline of the Achilles tendon. The
skin will be marked in order to decrease the variability of
pre-post testing electrode placement. The ground is placed
between the stimulator and electrodes (i.e., knee cap, fem-
oral condyle) and the amplifier is positioned at the hip
away from electrodes.
Stimulation procedure
Stimulation will be at the popliteal fossa with the top
prong (cathode) placed in the middle of the fossa and
superior to the bottom prong. The "Positive" end of the
stimulator (anode) is positioned inferiorly toward the
ankle. The arrow on the stimulator points in the direction
of the current flow. In this case, we want the current flow-
ing proximally toward spine. With the pulse width for
stimulation set at 1 ms, stimulation is started at a low
intensity. Intensity is increased in 1 milliampere (mA)
increments. The stimulator delivers pulses at regular inter-
vals (pulse width = 1000 ms) to the Ia afferents. Intensity
is gradually increased until an H wave appears. At this
point, intensity is increased at 1–2 mA per discharge until
the H wave reaches maximum, starts to decrease and the
M-wave appears. Intensity is now increased in larger incre-
ments (5–10 mA) until the H wave completely disappears
and the M-wave reaches a maximum.
Ankle range of motion (ROM) measurement
Following the second TMS MT measurement, all subjects
will receive 2 different ankle ROM measurements. In the
first measurement, subjects will lay prone on a padded
table. A single blinded and standardized examiner will
measure ankle dorsiflexion ROM with the knee fully
extended and then flexed to 90 degrees using a 15.24 cm
goniometer in a standard manner.[19] This measurement
of ankle ROM demonstrates strong test-retest reliability
with knee both flexed (ICC = .97) and extended (ICC =
.98).[19] A knee to wall measurement also will be
taken.[31] Standing with hand support on the wall, with
affected lower extremity anterior and the unaffected lower
extremity posterior. Subjects were required to move the
knee directly forward to a vertical line on the wall. No
attempt will be made to control the height of the medial
longitudinal arch during this measurement. For subjects
who are unable to touch their knee to the wall (1), the dis-
tance from the wall to the anterior aspect of the knee will
be measured and recorded in centimeters as a negative
value. Subjects who can touch the knee to the wall will
move the foot back until the knee could just touch the
wall (2). The distance from the wall to the great toe will be
recorded in centimeters as a positive value. The knee to
wall measurement of ankle ROM also demonstrates
strong test-retest reliability (ICC = .97).[31]
Lower extremity functional behavior measurement
Following the ankle ROM tests, all subjects will receive a
measurement of lower extremity functional behavior
involving a star balance excursion test (SBET) conducted
on a single limb. The SBET is a clinical test of dynamic bal-
ance.[32] Subjects will assume unilateral stance in the
center of a grid marked circumferentially in 45-degree
increments. After a learning trial consisting of 6 repeti-
tions in each of the 8 test directions[33], subjects will
complete 3 repetitions of single limb squat reach. Two tri-
als will be completed: 1 trial each with the subject stand-
ing on the affected and unaffected limbs. Test directions
include anterior, lateral, anterolateral, posterolateral, pos-
terior, medial, anteromedial, and posteromedial. The
evaluating therapist will record the distance achieved
between the stance toe and the contacting portion of the
reaching extremity for 3 repetitions in each direction. Fif-
teen seconds of rest will be provided between trials. Repe-
titions will be excluded if the subject (1) is unable to
maintain weightbearing during the trial; (2) lifts the
stance foot; (3) loses balance; or (4) does not maintain
the hold or start positions for 1 second. This test demon-
strates good reliability (ICC = .67–.97), and demonstrates
discriminative validity between non-disabled individuals
and patients with chronic ankle instability.[32,34]BMC Neurology 2009, 9:20 http://www.biomedcentral.com/1471-2377/9/20
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Intervention
Subjects will be randomized into 3 groups after pre-partic-
ipation screening is completed, informed consent is
obtained, and baseline measures are recorded. The first
group (n = 9) will receive an HVLA procedure directed to
the talocrural joint (Figure 3). With the subject in a seated
position on a treatment table and the lower extremity of
interest stabilized to the table with a belt, a standardized
licensed physical therapy (treating therapist) will grasp
the foot of interested with the thenar eminences on the
foot's plantar surface. A thrust will be delivered parallel to
the long axis of the subject's lower leg after the treating
therapist induces passive ankle dorsiflexion to end range.
The second group (n = 9) will receive a slow procedure
directed to the talocrural joint. Traction will be delivered
to the talocrural joint at the treating therapist's second
perception of tissue resistance in 3 bouts of 30-second
holds, separated by 10 seconds of rest. The third group (n
= 9) will receive the manual therapy control intervention.
This will consist of the same patient and clinician prepa-
ration for the mobilization/manipulation techniques.
However, the treating therapist will simply maintain pas-
sive DF ROM for the duration of 1 deep inhalation and
exhalation by the subject rather than induce an iatrogenic
force.
Post-intervention testing
Immediately following intervention, subjects will receive
a final administration of ankle ROM tests, lower extremity
functional behavior test, TMS, and H-reflex measure-
ments. After post-intervention testing, subjects will be dis-
charged from the study.
Data Analysis
TMS measurements
All TMS/EMG data will be analyzed off-line with a cus-
tomized MATLAB (Mathworks, MA, USA) software tool
for analysis of time-series data (dataWizard[35]). Each
TMS trial will be analyzed for both MEP and cortical silent
period (CSP) duration. At low intensities that did not cre-
ate a MEP, the maximal peak-to-peak envelope within the
time window for typical MEPs will be recorded as the MEP
value for that trial. The 8 MEPs occurring at each level of
intensity will be averaged. The CSP duration will be
defined as the time between TMS and the first return of
rectified EMG activity of at least 50% of pre-TMS back-
ground activity following a period of sustained silence.
The CSP duration will be calculated relative to TMS onset
because at lower intensities MEPs often will be absent
while CSPs can be detected. When no CSP can be dis-
cerned, CSP duration will be marked as 0 msec. Eight CSP
duration values will be averaged for each subject. The rela-
tionship between average MEP amplitude and CSP data
(output) and TMS intensity (input) will be fitted to a sig-
moid curve.[29,36] These sigmoid functions will then be
characterized by 3 parameters: maximal amplitude, maxi-
mal slope, and the midpoint intensity where amplitude is
half maximum. The ratio of the largest H and M wave
amplitudes also will be calculated (H/M ratio). If the ratio
remains the same pre and post ankle thrust then any
change in corticomotor excitability assessed through TMS
would be considered centrally mediated.
Functional behavior and ROM measurements
SBET measurements will be indexed to lower limb length
as measured from anterior superior iliac spine to medial
malleolus prior to data analysis. Two-sample t-tests with
appropriate correction will be used to determine the sta-
tistical significance of differences in pre- and post-inter-
vention ankle DF ROM, SEBT performance, and MEP/CSP
data. Test-retest reliability and minimum detectable
change will be determined for the 2 baseline measure-
ments of MEP/CSP data.[37,38] Pearson correlations with
appropriate statistical correction will be used to test the
significance of associations among ankle DF ROM, SBET
measurement, and TMS/EMG variables within subjects.
Ankle high-velocity low-amplitude, slow velocity, and control  interventions under study Figure 3
Ankle high-velocity low-amplitude, slow velocity, and 
control interventions under study. With the subject in a 
supine position on a treatment table and the lower extremity 
of interest stabilized to the table with a belt (A), the treating 
investigator will grasp the foot of interested with the thenar 
eminences on the foot's plantar surface (B) and induce pas-
sive dorsiflexion to end range (B; open arrow). Iatrogenic 
force will be provided along the long axis of the tibia in the 
intervention groups. (B; hatched line) In the control group, 
the treating investigator will maintain passive dorsiflexion (B; 
open arrow) for the duration of 1 deep inhalation and exha-
lation by the subject rather than induce an iatrogenic force.BMC Neurology 2009, 9:20 http://www.biomedcentral.com/1471-2377/9/20
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For all TMS, ROM, and lower extremity functional behav-
iour variables, two-factor multivariate analysis of variance
with repeated measures for time will be used to determine
the effects of repeated baseline testing and the interven-
tion under study on SBET performance and ankle ROM
measurements. Significant main effects will be reported if
there are no significant interactions. If significant interac-
tions are found, then one-way analysis of variance will be
completed for each variable. Post-hoc testing will be per-
formed as necessary with appropriate correction to deter-
mine the significance of pairwise comparisons. Pearson
correlations with appropriate statistical correction will be
used to test the significance of associations among ankle
DF ROM, SBET measurement, and TMS/EMG variables
within subjects.
Discussion
This study protocol describes one of the first reported fea-
sible study methodologies to date that is designed to iden-
tify potential neuromotor changes associated with
manual therapy procedures directed to the appendicular
skeleton. We believe the large muscles associated with the
talocrural joint and ability to localize the procedure to the
talocrural joint will better elucidate potential neuromotor
effects of manual therapy procedures than the studies to
date that have focused on spinal procedures. Further, we
will be able to compare the relative effect of treatment
speed on potential neuromotor effects of manual therapy
procedures in the context of a controlled study. Also, this
study will provide the ability to make inferences regarding
the functional relevance of changes in corticospinal excit-
ability through the use of measurements of lower extrem-
ity range of motion and functional behavior. These
characteristics will allow this study's data to further our
understanding of appropriate clinical management of
individuals with many forms of musculoskeletal dysfunc-
tion.
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